286 related articles for article (PubMed ID: 18061663)
1. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
[TBL] [Abstract][Full Text] [Related]
2. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
4. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
5. Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans.
Gottero C; Prodam F; Destefanis S; Benso A; Gauna C; Me E; Filtri L; Riganti F; Van Der Lely AJ; Ghigo E; Broglio F
Growth Horm IGF Res; 2004 Oct; 14(5):382-7. PubMed ID: 15336231
[TBL] [Abstract][Full Text] [Related]
6. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
Broglio F; Arvat E; Benso A; Gottero C; Prodam F; Grottoli S; Papotti M; Muccioli G; van der Lely AJ; Deghenghi R; Ghigo E
J Clin Endocrinol Metab; 2002 Aug; 87(8):3783-90. PubMed ID: 12161511
[TBL] [Abstract][Full Text] [Related]
7. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E
J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
[TBL] [Abstract][Full Text] [Related]
9. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
[TBL] [Abstract][Full Text] [Related]
10. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
[TBL] [Abstract][Full Text] [Related]
11. Cortistatin and pituitary hormone secretion in rat.
Baranowska B; Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L
J Physiol Pharmacol; 2009 Mar; 60(1):151-6. PubMed ID: 19439817
[TBL] [Abstract][Full Text] [Related]
12. Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.
Benso A; Gottero C; Prodam F; Gauna C; Destefanis S; Filtri L; van der Lely AJ; Deghenghi R; Ghigo E; Broglio F
J Endocrinol Invest; 2003 Jul; 26(7):599-603. PubMed ID: 14594107
[TBL] [Abstract][Full Text] [Related]
13. Brain-gut communication: cortistatin, somatostatin and ghrelin.
Broglio F; Papotti M; Muccioli G; Ghigo E
Trends Endocrinol Metab; 2007 Aug; 18(6):246-51. PubMed ID: 17632010
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
15. Direct effect of cortistatin on GH release from cultured pituitary cells in the rat.
Baranowska B; Chmielowska M; Wolinska-Witort E; Bik W; Baranowska-Bik A; Martynska L
Neuro Endocrinol Lett; 2006; 27(1-2):153-6. PubMed ID: 16648801
[TBL] [Abstract][Full Text] [Related]
16. Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin.
Córdoba-Chacón J; Gahete MD; Pozo-Salas AI; Martínez-Fuentes AJ; de Lecea L; Gracia-Navarro F; Kineman RD; Castaño JP; Luque RM
Endocrinology; 2011 Dec; 152(12):4800-12. PubMed ID: 21971153
[TBL] [Abstract][Full Text] [Related]
17. Endocrine actions of cortistatin: in vivo studies.
Broglio F; Grottoli S; Arvat E; Ghigo E
Mol Cell Endocrinol; 2008 May; 286(1-2):123-7. PubMed ID: 18281148
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
[TBL] [Abstract][Full Text] [Related]
19. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
Maccario M; Veldhuis JD; Broglio F; Vito LD; Arvat E; Deghenghi R; Ghigo E
Eur J Endocrinol; 2002 Mar; 146(3):310-8. PubMed ID: 11888836
[TBL] [Abstract][Full Text] [Related]
20. The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's disease.
Giordano R; Picu A; Bonelli L; Broglio F; Prodam F; Grottoli S; Muccioli G; Ghigo E; Arvat E
Eur J Endocrinol; 2007 Oct; 157(4):393-8. PubMed ID: 17893252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
